Miguel Escobar is tenured Professor of Internal Medicine and Pediatrics at the University of Texas Health Science Center, MD Anderson Cancer Center and the McGovern Medical School in Houston, Texas. He is also the Director of the Gulf States Hemophilia and Thrombophilia Center, the Clinical Research Center at the University and the Medication, Therapy and Wellness Center at the Memorial Hermann Hospital in Houston.

Dr Escobar received his MD from the Universidad Libre in Cali, Colombia and did his residency in Internal Medicine at the University of Connecticut and fellowship in hematology/oncology at the University of North Carolina at Chapel Hill, USA. He has won multiple awards, including the Physician of the year award from the National Hemophilia Foundation.

Dr Escobar is a member of the World Federation of Hemophilia Board of Directors and Chair of the Scientific and Standardization Subcommittee on FVIII/FIX & rare coagulation disorders for the ISTH. He has been involved in many clinical studies, including gene therapy resulting in a range of publications and is a member of several professional organisations. His main research interest is in haemophilia, congenital and acquired inhibitors and other coagulation deficiencies.

Prof. Miguel Escobar has received financial support/sponsorship for research support, consultation, or speaker fees from the following companies: